logo-loader
Frontier IP Group PLC

Frontier IP upgrades full year forecasts as portfolio firm Exscientia inks deal with biotech giant Celgene

The collaboration included an initial upfront payment of US$25mln for Exscientia in addition to “substantial milestones” and tiered royalties on net sales of any product developed

Celgene logo
New Jersey-based Celgene focuses on medicines for cancer and inflammatory diseases and has a market cap of around US$62.6bn

Frontier IP Group PLC (LON:FIPP) shares were given a boost in mid-morning on Thursday after Exscientia, an artificial intelligence (AI)-driven drug discovery firm in which it has a 3.32% stake, signed a three-year deal with US biotech giant Celgene Corp (NASDAQ:CELG).

The IP commercialisation group said the collaboration, which will focus on oncology and autoimmunity, included an initial upfront payment of US$25mln for Exscientia, in addition to “substantial milestones” and tiered royalties on net sales of any product developed.

READ: Frontier IP jumps as The Vaccine Group partners up with US defense research agency to fight Ebola

New Jersey-based Celgene focuses on medicines for cancer and inflammatory diseases and has a market cap of around US$62.6bn.

Frontier IP’s chief executive Neil Crabb said the agreement with Celgene joined “an impressive list of collaboration agreements struck by Exscientia”, which include deals with Swiss healthcare group Roche, FTSE 100 firm GlaxoSmithKline PLC (LON:GSK), French pharma group Sanofi, and Germany’s Evotec.

Full-year forecasts upgraded

In a separate trading update, Frontier said based on trading to date for its current fiscal year and a number of "positive portfolio developments" since the start of 2019, its results for the full year were now expected to be “ahead of management expectations”.

Shares were up 4.9% at 86p.

Quick facts: Frontier IP Group PLC

Price: 63 GBX

Market: AIM
Market Cap: £31.77 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Frontier IP Group PLC named herein, including the promotion by the Company of Frontier IP Group PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Frontier IP Group 'well positioned for another positive performance'

Frontier IP Group PLC's (LON:FIPP) Neil Crabb tells Proactive London's Andrew Scott he's confident their portfolio will continue to grow after profits in its latest full-year increased 160%. The fair value of the group’s investment portfolio also increased by 47% to £13.25mln, while it ended...

on 8/11/19

RNS

Holding(s) in Company

1 day, 17 hours ago

Holding(s) in Company

1 day, 17 hours ago

Holding(s) in Company

1 day, 18 hours ago

Holding(s) in Company

1 day, 22 hours ago

Grant of Options

2 days, 1 hour ago

Holding(s) in Company

4 days, 14 hours ago

Holding(s) in Company

5 days, 20 hours ago

2 min read